Ogivri - NDC Database
6 records found
Page:
67457-845 Nov 29, 2019
Ogivri 420 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
Ogivri 420 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
67457-991 Nov 29, 2019
Ogivri 150 mg/7.4ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
Ogivri 150 mg/7.4ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
83257-001 Oct 01, 2023
Ogivri 150 mg/7.4ml Intravenous Injection, Powder, Lyophilized, for Solution by Biocon Biologics Inc.
Ogivri 150 mg/7.4ml Intravenous Injection, Powder, Lyophilized, for Solution by Biocon Biologics Inc.
83257-003 Oct 01, 2023
Ogivri 420 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Biocon Biologics Inc.
Ogivri 420 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Biocon Biologics Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.